MedPath
FDA Approval

Ultramicrosize Griseofulvin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Chartwell RX, LLC.
DUNS: 079394054
Effective Date
October 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Griseofulvin(250 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Chartwell Pharmaceuticals Congers, LLC.

Chartwell RX, LLC.

118673447

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ultramicrosize Griseofulvin

Product Details

NDC Product Code
62135-495
Application Number
ANDA061996
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 5, 2023
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Code: 32HRV3E3D5Class: ACTIBQuantity: 250 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3BClass: IACT

Ultramicrosize Griseofulvin

Product Details

NDC Product Code
62135-494
Application Number
ANDA061996
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 5, 2023
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3BClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Code: 32HRV3E3D5Class: ACTIBQuantity: 125 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath